The Patent Finder

Targeting of Human Interferon Antagonists

Universite de Montpellier

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/EP2014/063976, filed Jul 1, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,732,135Targeting of Human Interferon Antagonists
In force
 · High confidence
UsedRemaining
Université de MontpellierIn forceHigh confidence
US 10,072,059Targeting of Human Interferon Antagonists
In force
 · High confidence
Université de MontpellierIn forceHigh confidence
US 10,947,288Targeting of Human Interferon Antagonists
In force
 · High confidence
Université de MontpellierIn forceHigh confidence
US 12,741,998Targeting of Human Interferon Antagonists
In force
 · Medium confidence
Université de MontpellierIn forceMedium confidence
Application 16/008,695Targeting of Cytokine Antagonists
Abandoned
Abandoned Mar 30, 2019
Université de MontpellierAbandonedAbandoned Mar 30, 2019
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Universite de Montpellier.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited